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Cardiovascular physicians frequently encounter vascular dis-
eases. Atherosclerosis and thrombosis, in particular, are
systemic disorders with clinical manifestations in most
peripheral circulations. These and other vascular diseases
account for substantial cardiovascular morbidity and mor-
tality. Moreover, technological advances in imaging tech-
niques and catheter-based interventions have brought man-
agement of vascular diseases firmly into the sphere of the
cardiovascular specialist. Training in vascular medicine
should be incorporated in a cardiovascular fellowship in
order to accommodate the clinical demands of this contem-
porary paradigm. Accordingly, 3 levels of training in vascu-
lar medicine are described.
Level 1—Basic training in vascular medicine that all
fellows should receive to acquire a sufficient knowledge base
to care for many patients with vascular disease.
Level 2—Additional training for fellows who wish to
develop special expertise in evaluating and managing pa-
tients with vascular disease. This level does not include
training in catheter-based interventions.
398 Creager et al. JACC Vol. 51, No. 3, 2008
ACCF COCATS 3 Training Statement: Task Force 11 January 22, 2008:398–404
Level 3—Training for noncoronary peripheral vascular
catheter-based vascular interventions. This level of training
is to ensure that the fellow develops both the cognitive and
technical skills requisite to making appropriate decisions
regarding invasive and interventional treatment of patients
with vascular disease.
Level 1: Basic Training for All
Cardiovascular Fellows
The essentials of vascular medicine should be taught to all
fellows. Vascular medicine training should be integrated into
the fellowship program and include the evaluation and man-
agement of vascular diseases, exposure to noninvasive diagnos-
tic modalities, angiography, and peripheral catheter-based
interventions. The equivalent of at least 2 months of the
fellowship, either as dedicated rotations or in the aggregate as
an integral component of other rotations, should be devoted to
vascular medicine. Acquisition of this fundamental knowledge
will permit the fellow to recognize a broad array of vascular
diseases and common medical disorders associated with vascu-
lar disease, to initiate appropriate medical management, and to
appropriately refer patients to a vascular specialist when nec-
essary for further evaluation and intervention. This level of
training, however, is not sufficient to qualify the trainee as a
vascular specialist capable of managing complex vascular pa-
tients.
Components of Training
The fellow should receive training in the evaluation and
management of arterial, venous, and lymphatic diseases,
such as peripheral arterial disease, acute arterial occlusion,
carotid artery disease, renal artery stenosis, aortic aneurysm,
vasculitis, vasospasm, venous thrombosis and insufficiency,
and lymphedema (Table 1). Training should also include
instruction in the recognition and management of medical
disorders associated with vascular diseases, including hyper-
tension, hypercholesterolemia, diabetes mellitus, and hyper-
coagulable states. Fellows should also be trained to perform
a comprehensive pre-operative evaluation of the patient
undergoing vascular surgery, to be cognizant of the indica-
tions and risks of pre-operative testing, and to manage
cardiovascular problems in the perioperative period.
Trainees should receive instruction in the noninvasive
vascular laboratory and know the indications for vascular
tests, such as segmental pressure measurements, pulse-
volume recordings, and duplex ultrasonography, as well as
the information that can be derived from such testing.
Furthermore, the fellow should understand the imaging
techniques that can be used to further assess the aorta, vena
cavae, and peripheral arteries and veins, such as computed
tomography angiography (CTA) and magnetic resonance
angiography (MRA), and recognize the indications for
catheter-based interventions and surgical revascularization.
All cardiovascular medicine fellowship candidates should
participate in noncardiac peripheral angiography (i.e., aorto-
graphy; angiography of first-order branch vessels of the aorta,
such as the iliac, renal, or subclavian arteries; and second-order
branch vessels, such as the internal mammary arteries; and
pulmonary angiography) in patients with whom they are
involved from pre-catheterization clinical evaluation to final
disposition. This training will not qualify the trainee to
independently perform peripheral angiography.
Structure of the Level 1 Training Program
Faculty
In a few institutions, leadership for the vascular medicine
component of the training program will come from vascular
Summary of Training Requirements for Vascular Medicine and Peripheral Catheter-Based Interventions
Table 1 Summary of Training Requirements for Vascular Medicine and Peripheral Catheter-Based Interventions
Level
Duration of Training
(Months) Components of Training Cumulative Number of Procedures*
1 2 Evaluation and management of arterial, venous, and
lymphatic disease, atherosclerotic risk factors, and
hypercoagulable states
Noninvasive vascular laboratory and vascular imaging
(i.e., ultrasound, MRA, CTA)
2 (vascular medicine
specialist)†
12 Outpatient vascular medicine clinic
Inpatient vascular medicine consultation service
Noninvasive vascular laboratory, examinations
MRA/CTA
Peripheral vascular catheterization
Vascular surgery
Noninvasive vascular lab
100 venous ultrasounds
100 carotid artery ultrasounds
100 limb artery ultrasounds
75 renal/mesenteric vascular ultrasounds
100 physiologic arterial examinations
3 (peripheral vascular
intervention)‡
12 Outpatient vascular medicine clinic
Inpatient medical consultation service
Vascular imaging, including ultrasound, MRA,
CTA (1 to 2 months)
Peripheral vascular catheterization and intervention
Peripheral vascular interventions
100 diagnostic peripheral angiograms
50 peripheral angioplasties/tents
10 peripheral thrombolytic
infusions/thrombectomy
*These are estimates based on the most recently published guidelines and will be kept current as guidelines are updated. After completing Level 1, trainees can elect to pursue Level 2 training, Level 3
training, or both, emphasizing either the medical evaluation and management of the vascular patient and the noninvasive vascular laboratory (Level 2) or peripheral vascular catheter-based interventions
(Level 3). Level 2 training is not a prerequisite for Level 3 training but is intended for individuals who want to become a vascular medicine specialist. †The prerequisite for Level 2 training is Level 1 training
in vascular medicine. ‡The prerequisite for Level 3 training includes Level 1 training in vascular medicine, and Level 1 and Level 2 training in diagnostic cardiac catheterization. Requirements for Level 3
training in peripheral vascular intervention can be fulfilled during a fourth year of interventional training focused on peripheral vascular intervention or concurrently with cardiac interventional training.
CTA  computed tomography angiography; MRA  magnetic resonance angiography.
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medicine specialists. In many programs, however, the exposure
to vascular medicine will come from faculty in other disciplines,
such as cardiology, hematology, neurology, vascular surgery,
and vascular radiology. All faculty responsible for training
fellows in vascular medicine should be board certified or board
eligible and recognized as experts in their subspecialties.
Facilities
The principal training institution should have facilities to
care for patients with vascular disease that include a nonin-
vasive vascular laboratory accredited by the Intersocietal
Commission for the Accreditation of Vascular Laboratories
(ICAVL), a peripheral vascular catheterization laboratory, a
comprehensive vascular surgery program, and offices for
outpatient evaluation and treatment.
Content of Conferences
Conferences should incorporate case presentations and for-
mal lectures that review current diagnostic and therapeutic
approaches to arterial, venous, and lymphatic disease. Case
presentations should illustrate the use of clinical tools,
noninvasive laboratory testing, and angiography. Confer-
ences should provide the trainee with information regarding
the natural history of peripheral vascular disorders, the
long-term risks and benefits of peripheral intervention, and
noninterventional approaches to vascular disease. Formal
lectures on the pathobiology of vascular diseases, including
atherosclerosis, restenosis, and thrombosis, should be incor-
porated.
Trainee Evaluation
The fund of knowledge regarding vascular disease must be
evaluated in every trainee. Quality of clinical skills; reliabil-
ity; judgments or actions that result in patient complica-
tions; and interaction with other physicians, patients, and
laboratory support staff are key components of the evalua-
tion. Initiative and ability to make independent and appro-
priate decisions are to be considered. The program director
has the responsibility to confirm or deny the experience and
competence of trainees.
Level 2: Requirements for Training Fellows
Wishing to Pursue a Career in
Vascular Medicine
Fellows planning a career in vascular medicine require a
distinct and comprehensive training program. In addition to
the 24 months required for board eligibility in cardiovascu-
lar medicine, another 12 months of training, typically
during a third or fourth year, should provide a curriculum to
enable the fellow to become an expert in vascular medicine
(1,2). The prerequisite for Level 2 training is Level 1
training in vascular medicine. The fellow who wishes to be
trained in peripheral vascular intervention will require ad-
ditional training as outlined in later text (see Level 3).
Components of Training
Trainees who plan a vascular medicine track as part of their
cardiovascular fellowship should spend at least 2 to 3
months on an inpatient vascular medicine consultation
service; 3 months in the noninvasive vascular laboratory; 1 to
2 months learning MRA and CTA; and 1 to 2 months in
the peripheral vascular catheterization laboratory (Table 1).
In addition, at least one-half to 1 day per week throughout
the year should be spent in the outpatient vascular medicine
clinic. In addition, there should be sufficient exposure to the
diagnosis and treatment of peripheral arterial disease, aortic
diseases, cerebrovascular disease, renal artery stenosis, ve-
nous thromboembolic diseases, chronic venous disorders,
lymphatic diseases, vasculitides, atheromatous embolization,
vasospastic disease, and chronic venous insufficiency, as well
as other uncommon vascular diseases.
The time spent on the inpatient hospital service and
outpatient clinic should include experience with risk factor
modification, including smoking cessation interventions and
treatment of dyslipidemia, hypertension, and thrombophilic
disorders, because these are important components of many
vascular diseases. Additional rotations could be allocated to
vascular surgery, hematology, neurology, and rheumatology
to acquire fundamental experience in these important areas
as they relate to vascular medicine.
Expertise in the noninvasive vascular laboratory is one of
the most important aspects of training for the vascular
medicine specialist. Although the principles of ultrasound
are the same whether one is performing an echocardiogram
or a vascular ultrasound, there are many important differ-
ences in technique and interpretation that require special
training. The trainee should understand the principles of
ultrasound physics, Doppler characteristics, and transducer
technology. The fellow should perform and interpret the
following vascular studies under supervision: 1) duplex
ultrasonography of the veins and arteries of the upper and
lower extremities; 2) the aorta; 3) the renal and mesenteric
arteries and veins; 4) the carotid arteries; 5) infrainguinal
bypass grafts; and 6) physiologic tests of peripheral arteries
and veins, among others. The number of noninvasive
vascular laboratory procedures required for each of the
studies performed in the vascular laboratory should follow
the guidelines recommended by the ICAVL (3). These
include, but are not limited to, 100 venous, 100 periph-
eral artery (including bypass grafts), 100 carotid artery,
and 75 visceral artery and venous (renal and mesenteric)
duplex ultrasound studies, as well as 100 physiologic
arterial examinations.
In addition, dedicated time should be spent learning the
basic principles of MRA and CTA. The trainees should
acquire the cognitive and clinical skills necessary to review
the MRA and CTA of peripheral vessels, including the
aorta, and brachiocephalic, limb, renal, and mesenteric
arteries when evaluating patients with vascular disease. This
experience is not intended to qualify the trainee in the
400 Creager et al. JACC Vol. 51, No. 3, 2008
ACCF COCATS 3 Training Statement: Task Force 11 January 22, 2008:398–404
performance and formal interpretation of MRA or CTA.
Expertise in MRA and CTA will require additional time to
acquire the comprehensive skills needed to perform and
independently interpret these imaging modalities (see the
Task Force 12 and 13 reports).
During the period of training in the catheterization labora-
tory, the fellow should learn the fundamentals of angiography
and peripheral catheter-based interventions. The trainee
should participate in peripheral diagnostic angiograms and
peripheral interventions, including angioplasty, stent implan-
tation, and thrombolysis. Training should emphasize interpre-
tation of angiograms and permit the fellow to acquire an
understanding of the indications and potential outcomes of
invasive diagnostic procedures and catheter-based treatments.
This experience is not intended to qualify the trainee as an
interventionalist (see Level 3).
Structure of the Level 2 Training Program
Faculty
The trainee should be exposed to individuals who have
special training in vascular medicine and cardiovascular
diseases. Ideally, these faculty will be board certified in
vascular medicine and/or endovascular medicine by the
American Board of Vascular Medicine. It is recognized,
however, that this may not be possible at all institutions.
Therefore, the cardiovascular fellow may need to spend time
in other departments or divisions to gain the necessary
expertise to be a vascular medicine specialist. As per Level 1
training, all faculty responsible for training fellows in
vascular medicine should be board certified or board eligible
and recognized as experts in their subspecialties. Areas
where this may be most important include the noninvasive
vascular laboratory, angiography suite, vascular surgery,
hematology, neurology, and rheumatology. The faculty
should be required to provide didactic and practical educa-
tion to the fellow, as well as appropriate feedback about the
trainee’s performance.
Facilities
Adequate space should be available in the outpatient clinics
to see patients. The noninvasive vascular laboratory should
be accredited by the ICAVL and have equipment of suitable
quality to perform all of the studies previously listed. There
should be dedicated, fully equipped areas for magnetic
resonance and computed tomographic imaging. A periph-
eral vascular catheterization laboratory equipped as stated in
the following text should also be a requirement for the
cardiovascular fellow’s training in vascular medicine. There
should be an active and comprehensive vascular surgery
program at the institution, and facilities for treatment of leg
ulcers should be available.
Content of Conferences
The cardiovascular fellowship program should have a com-
prehensive conference series for topics of importance for the
vascular medicine specialist. A conference dedicated to a
core curriculum of topics should be scheduled throughout
the year. Additional conferences could include angiography
and imaging, vascular medicine grand rounds, a journal
club, and morbidity and mortality.
Evaluation of Trainee and Faculty
As with every successful post-graduate training program,
this program requires bi-directional evaluations. The faculty
evaluates and provides positive and negative feedback to the
trainee, and the trainee evaluates the faculty. Formal eval-
uations of the fellows and faculty should occur after each
rotation. The program director should review these evalua-
tions with the trainee and with the faculty individually.
Mechanisms should be incorporated into the training pro-
gram so that the fellow who performs suboptimally can be
counseled and further action can be taken if necessary. The
American Board of Vascular Medicine administers a certi-
fying examination in vascular medicine. The fellow will be
expected to take and pass this examination.
Level 3: Training for Peripheral Vascular
Catheterization and Intervention
Catheter-based peripheral angiography (arterial and venous)
and interventional procedures are important components of
a modern clinical cardiovascular practice. The trainee who
plans to perform peripheral catheter-based angiography and
interventions will be required to complete an additional
period of training in these special procedures to obtain the
basic fund of knowledge, technical skills, and the clinical
judgment requisite for performing these invasive studies (1).
Components of Training
Trainees who plan to perform independent peripheral vas-
cular catheterization (arteriography and venography) and
interventions must become knowledgeable about normal
vascular anatomy and common anatomic variants and be-
come familiar with the common patterns of collateral
formation. They must learn the theoretical and practical
aspects of radiation physics and safety. A working knowl-
edge of the cardiovascular angiographic laboratory equip-
ment, including physiologic recorders, pressure transducers,
blood gas analyzers, image intensifiers, cine processing,
digital imaging, and image archiving, is required. An
understanding of the fundamental principles of pressure
waveform recording and analysis is mandatory.
Trainees should receive specific training in the techniques
of vascular access from multiple sites (femoral, popliteal, and
upper extremity arteries and veins). They should be trained
to manipulate guidewires and catheters, place and deploy
angioplasty equipment and devices, perform catheter-
directed thrombolysis/thrombectomy, and obtain hemosta-
sis via the application of compression and vascular closure
devices. They should acquire the ability to perform vascular
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interventions in each of the following: aorta and lower
extremity arteries, cervical arteries, brachiocephalic and
upper extremity arteries, mesenteric and renal arteries,
central and peripheral veins, and pulmonary arteries. Train-
ees must learn the indications, limitations, and complica-
tions of vascular interventional procedures, and understand
the alternative treatments.
Level 3 training in peripheral angiography and catheter-
based peripheral vascular intervention must also provide the
fellow with the cognitive tools requisite to evaluating and
managing patients with vascular disease. In some respects,
this overlaps with Level 2 training. Trainees should spend
the equivalent of 1 month on an inpatient vascular consul-
tation service, 1 to 2 months dedicated to vascular imaging
(including duplex ultrasonography, and MRA and CTA),
and 1 half-day per week in an outpatient vascular clinic to
acquire the knowledge necessary to manage patients with
peripheral arterial disease, aortic diseases, renal artery ste-
nosis, cerebrovascular disease, venous thrombosis, and other
relevant vascular diseases (Table 1). The trainees should
acquire the cognitive and clinical skills necessary to review
duplex ultrasound studies of peripheral arteries and veins as
well as the MRA and the CTA of peripheral vessels,
including the aorta, and brachiocephalic, limb, renal, and
mesenteric arteries when evaluating patients with vascular
disease as described for Level 2 training. This experience is
not intended to qualify the trainee in the performance and
formal interpretation of vascular ultrasound studies, MRA,
or CTA. Level 2 training is not a prerequisite for Level 3
training but is suggested for those wishing to acquire
comprehensive training in vascular medicine in order to
complement skills developed during Level 3 training.
Structure of the Level 3 Training Program
Faculty
The training program must have a director of the catheter-
ization laboratory who has primary responsibility for admin-
istration and teaching. The program director must be board
certified in interventional cardiology or have equivalent
credentials. More than 1 faculty member is required to
participate in the peripheral interventional training of the
fellows. All faculty responsible for training fellows in
catheter-based peripheral angiography and intervention
should be board certified or board eligible by the American
Board of Internal Medicine (ABIM) Subspecialty Board on
Cardiovascular Disease and recognized by his or her peers as
an expert in peripheral catheter-related intervention. Ide-
ally, faculty should have received additional certification in
cardiovascular intervention by the ABIM Subspecialty
Board on Cardiovascular Disease or passed the American
Board of Vascular Medicine Endovascular Examination.
Facilities
A fully equipped and staffed angiographic and hemody-
namic laboratory dedicated to cardiovascular procedures is
required. All training facilities must be equipped and staffed
and function in accordance with the most recent American
College of Cardiology (ACC) recommendations for periph-
eral transluminal angioplasty, training, and facilities. Pe-
ripheral vascular surgery must be performed in the training
institution to support catheter-based interventions.
Patients
All trainees should be exposed to adult patients with
vascular diseases as outlined in the previous text. These
include patients with peripheral arterial disease, aortic dis-
eases, cerebrovascular disease, renal artery stenosis, venous
thromboembolic diseases, vasculitides, atheromatous embo-
lization, and uncommon vascular diseases.
The trainee planning a career in angiography and
catheter-based vascular interventions must be trained to
perform procedures in acutely and chronically ill patients,
including emergency patients with acute limb ischemia.
Duration of Training
For the cardiovascular trainee who plans to independently
perform peripheral angiography and catheter-based periph-
eral vascular interventions, Level 1 training in vascular
medicine, and Level 1 and Level 2 training in the cardiac
catheterization laboratory are required as a prerequisite (also
see the Task Force 3 report). Requirements for Level 3
training in peripheral vascular intervention can be fulfilled
during a fourth year of interventional training focused on
peripheral vascular intervention or concurrently with cardiac
interventional training.
For trainees planning to perform peripheral vascular
interventional procedures, dedicated peripheral vascular in-
terventional fellowship training is required, during which
time the minimum requirements specified by the Clinical
Competence Statement on Vascular Medicine and Catheter-
Based Peripheral Vascular Interventions must be met (1).
These requirements can be met during a fourth year of
interventional training focused on peripheral vascular inter-
vention or concurrently with cardiac interventional training.
Current guidelines for competence indicate that trainees
should perform at least 100 diagnostic angiograms, 50
peripheral angioplasties, and 10 peripheral thrombolytic/
thrombectomy interventions.
Content of Conferences
All trainees must attend a regular cardiovascular catheterization
and angiography conference. It is important that the cardiol-
ogist understand the complexities and limitations of the car-
diovascular angiographic laboratory. Formal conferences
should stress the relation of medical history, physical exami-
nation findings, hemodynamic findings, and angiographic
findings for the selection of patients for therapy (i.e., medicine,
surgery, or intervention). Interaction with the other vascular
specialists at these conferences is important.
The trainee should be familiar with the rationale for patient
selection for these diagnostic studies and should be required to
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attend conferences at least weekly for the duration of the
catheterization/angiography rotation. Attendance at regular
morbidity and mortality conferences is a requirement.
Trainee Evaluation
Case selection and procedural judgment, as well as interpretive
and technical skills, must be evaluated in every trainee. This is
particularly important for the trainee who eventually will work
full time in a diagnostic cardiovascular angiography laboratory
or perform catheter-based vascular interventional procedures.
Quality of the clinical follow-up; reliability; judgments or
actions that result in patient complications; interaction with
other physicians, patients, and laboratory support staff; appro-
priate initiative; and the ability to make independent and
appropriate decisions should be considered.
The competence of all cardiology trainees in cardiovas-
cular angiography and intervention should be documented
by both the program director and the director of the
catheterization laboratory. The program director has the
responsibility to confirm or deny the technical competence
and catheterization laboratory exposure of trainees. The
granting of hospital privileges remains within the purview of
the individual institution.
Evaluation of the trainee who undertakes special training
in catheter-based peripheral angiography and vascular in-
tervention shall include the documentation (in the form of
a logbook containing clinical information, procedure per-
formed, and outcome of the procedure, including any
complications experienced by the patient) of the perfor-
mance of at least the minimum number of procedures set
forth in the Clinical Competence Statement on Vascular
Medicine and Catheter-Based Peripheral Vascular Inter-
ventions (1). Evaluation of the trainee for catheter-based
peripheral vascular intervention shall include the documen-
tation (in the form of a logbook) of the performance of at
least the minimum number of procedures set forth in the
Clinical Competence Statement (1).
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Cardiovascular magnetic resonance (CMR) (Table 1), one
of the newest cardiovascular imaging modalities, provides
useful, often unique information with which all cardiologists
should be conversant. Accordingly, cardiovascular trainees
should receive training that would provide at least a basic
understanding of the methods and utility of CMR in the
practice of cardiology. To accomplish such an understand-
ing for fellows with different levels of interest in CMR,
training in CMR should be provided at 3 levels—general,
specialized, and advanced.
Training Levels
Level 1—General training (1 month) should provide the
cardiovascular trainee with a working knowledge of CMR
methods and their diagnostic utility.
Level 2—Specialized training (at least 3 months) de-
signed to provide the trainee in cardiovascular diseases with
the skills necessary to independently interpret CMR imag-
ing studies.
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